Susquehanna International Group’s GlucoTrack GCTK Stock Holding History

Susquehanna International Group’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2	Closed	-$4.52K	–	12439
2024 Q1	$4.52K	Buy	+2	New	+$3.14K	﹤0.01%	11959
2023 Q2	–	Sell	-3	Closed	-$5.62K	–	12441
2023 Q1	$5.62K	Buy	3 +1	+50%	+$5.89K	﹤0.01%	12293
2022 Q4	$15.5K	Buy	+2	New	+$20.5K	﹤0.01%	11842
2022 Q1	–	Sell	-2	Closed	-$48K	–	13339
2021 Q4	$48K	Buy	+2	New	+$46.5K	﹤0.01%	12569

Other funds holding GCTK

Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's GCTK Position: Q2 2024 in Review

Susquehanna International Group sold out of GlucoTrack (GCTK) in Q2 2024, closing a stake of 2 shares — an estimated $4.52K sold.

Susquehanna International Group first reported a position in GCTK in Q4 2021 and held it in 4 quarters. The position peaked at $48K in Q4 2021. 3 funds tracked by Wall St. Rank hold GCTK as of Q2 2024.

Susquehanna International Group reported no remaining GlucoTrack position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 2 GlucoTrack shares in Q2 2024, an estimated $4.52K.
Susquehanna International Group first reported a position in GlucoTrack in Q4 2021 and held it in 4 quarters.
Susquehanna International Group's GlucoTrack position peaked at $48K in Q4 2021.
3 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.